What You Should Know:
- NIH awards funding for Rare and Atypical Diabetes
Network, or RADIANT that will seek to discover the cause of
several unusual forms of diabetes.
- RADIANT plans to screen about 2,000 people with unknown
or atypical forms of diabetes that do not fit the common features of type 1 and
type 2 diabetes.
The National Institute of
Health (NIH), announced this week it is funding a nationwide study with The Rare and Atypical Diabetes
Network (RADIANT) that will seek
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Is Glucometrics The Missing Data in the Fight Against COVID-19?
Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients.
Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack, battling pneumonia, or recovering from surgery.
The U.S. health system lacks
Read More
Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe
What You Should Know:
- Abbott has received CE Mark (European approval)
for its next-generation FreeStyle Libre 3 system for people with diabetes.
- FreeStyle Libre 3 is the latest advancement from
Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest
continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies)
and a more environmentally sustainable system design.
Abbott, the worldwide
leader in continuous glucose
Read More
Ascensia Diabetes Care Partners With VisiQuate to Expand Beyond Blood Glucose Monitoring
What You Should Know:
- Ascensia Diabetes Care and VisiQuate announced a
partnership to expand beyond blood glucose monitoring and provide holistic
diabetes management solutions.
- The overall solution will provide integration with
Ascensia’s existing devices and digital diabetes solutions to enable it to
capture data from patients who have consented to provide their information.
Ascensia Diabetes Care,
a Santa Rosa, CA-based provider of blood glucose monitoring systems
Read More
FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes
What You Should Know:
- Medtronic announced the U.S. Food and
Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump
system with smartphone connectivity and an expanded age indication to patients
with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for
an automated insulin pump system.
- The new
MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app
(compatible with both iPhone and Android), and Roche Accu-Chek®
Read More
One Drop Launches Digital Membership for Whole-Person Approach to Chronic Condition Self-Care
What You Should Know:
- One Drop has expanded its consumer offering beyond
diabetes management with data-driven tools and personalized support for people
living with diabetes, prediabetes, high blood pressure, high cholesterol, or
any combination of these conditions.
One Drop, a New
York City-based provider of digital health solutions
for people living with diabetes and other chronic conditions, today announced
the launch of its Digital
Membership, a new direct-to-consumer subscription
Read More
Medtronic Acquires Smart Insulin Pen Company Companion Medical
What You Should Know:
- Today, Medtronic announced that it will
acquire Companion Medical, the manufacturer of InPen, a smart insulin pen
system paired with an integrated diabetes management app.
- The addition of Companion’s InPen system builds
upon Medtronic's strategic acquisitions of Nutrino and Klue to further
improve overall automated decision-making capabilities and optimizes dosing
decisions using algorithms and AI for patients.
Medtronic,
today announced the
Read More
DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care
What You Should Know:
- DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.
- DreaMed uses AI-powered technology to seamlessly treat
patients remotely with its virtual diabetes management service by
Read More
Current Health, Dexcom Partner to Deliver Continuous, Remote Glucose Monitoring
What You Should Know:
- Current Health has partnered with Dexcom to add continuous
glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM)
platform – enhancing care and improving outcomes for diabetics.
- Dexcom CGM data will transmit directly into the Current
Health wearable and platform for review by the care management and clinical
teams, improving post-discharge and chronic care of diabetes patients outside
the hospital.
- Through this partnership, Current
Read More
Inovalon Launches FHIR-Based Solution for Health Plan Compliance
What You Should Know:
- Inovalon announced the availability of its Cloud-Based “Consumer Health Gateway” Module, alleviating the need for health plans to build their own Patient Access API to comply with the new requirement of the 21st Century Cures Act.
- The Consumer Health Gateway is a consumer portal allowing the FHIR®-based exchange of a patient’s claims and clinical data securely with authorized third-party applications. It consists of a robust patient consent and authentication
Read More
